![]() |
|||||||||||||||||
|
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
|||||||||||
|
![]() |
![]() |
EID Home | Ahead of Print | Past Issues | EID Search | Contact Us | Announcements | Suggested Citation | Submit Manuscript PDF
Version
| Download Adobe Acrobat
| Comments |
|
![]()
|
![]() |
Research Emergence of Ceftriaxone-Resistant Salmonella Isolates and Rapid Spread of Plasmid-Encoded CMY-2–Like Cephalosporinase, TaiwanJing-Jou Yan,* Wen-Chien Ko,* Cheng-Hsun Chiu,† Shu-Huei Tsai,* Hsiu-Mei
Wu,* and Jiunn-Jong Wu*
Because of increasing rates of antimicrobial resistance in salmonellae
worldwide (1-4), extended-spectrum cephalosporins, especially
ceftriaxone, are frequently used to treat invasive salmonellosis. Since
the early 1990s, ceftriaxone-resistant salmonellae have been noted in
many countries, including France, Argentina, Algeria, Tunisia, Turkey,
Spain, Latvia, the United States, and Hungary (5-17),
with resistance conferred by various class A extended-spectrum Although the prevalence of multidrug-resistant salmonellae is a major public health concern, ceftriaxone-resistant salmonellae have not yet been reported in Taiwan (4,20,21). We conducted a retrospective survey of clinical Salmonella isolates collected over a 4-year period in a teaching hospital to investigate whether ceftriaxone-resistant salmonellae have emerged in Taiwan. Two ceftriaxone-resistant strains producing a CMY-2–like class C cephalosporinase were found. We also established a connection between the appearance of the resistant strains and the rapid spread of the blaCMY-2-like gene in this area. Materials and MethodsBacterial Isolates and PatientsFrom January 1997 to December 2000, a total of 384 Salmonella isolates from 324 patients were collected at the National Cheng Kung University Hospital, a tertiary-care referral center with 900 beds in southern Taiwan. According to the criteria of the National Committee for Clinical Laboratory Standards (NCCLS) for the disk diffusion method, we selected for further investigation the isolates that exhibited resistance or intermediate resistance to cefpodoxime, ceftazidime, aztreonam, cefotaxime, ceftriaxone, cefoperazone, or cefixime (22). For comparison, 5,520 E. coli isolates and 3,680 K. pneumoniae isolates collected during the same period were included. Of these isolates, 1,210 nonrepetitive E. coli isolates collected from January to September 1999 were investigated previously (23). The 1997 and 1998 isolates were randomly collected and the 1999 and 2000 isolates were consecutively collected. Salmonella isolates were serotyped according to the Kauffman and White scheme (24) by using somatic and flagellar antigens (Becton Dickinson Microbiology, Cockeysville, MD). We reviewed the medical records of patients infected with or colonized by the organisms being studied. Patients who provided samples positive for the organisms collected from any body site but who had no related signs or symptoms of infections were considered colonized. Nosocomial acquisition of infections in the teaching hospital was defined according to the 1988 definitions from the Centers for Disease Control (25). Patients transferred from other hospitals or nursing homes with infections occurring <48 h after admission were considered to have acquired the infections at the other locations. Hospitalization histories for the previous locations were recorded for outpatients and for inpatients who were colonized by the studied organisms and who provided samples within 48 h after admission. Susceptibility TestingThe susceptibilities of isolates to antimicrobial agents were determined by using the agar dilution or disk diffusion method according to the NCCLS guidelines (22,26). The antimicrobial agents used for the agar dilution test included amoxicillin, clavulanic acid, ceftriaxone, cefoxitin, ceftazidime, cefotaxime, and imipenem. Sources of antimicrobial agents used in this study are described elsewhere (23). Breakpoints used for susceptibility meet NCCLS criteria; the ceftazidime, cefotaxime, and ceftriaxone breakpoint was 8 µg/mL (26). Isoelectric FocusingCrude β-lactamase extracts were prepared by using sonication (27)
as described previously (23). We performed isoelectric
focusing by the method of Matthew et al. (28) with an
LKB Multiphor apparatus on prepared PAGplate gels (pH 3.5 to 9.5; Amersham
Pharmacia Biotech, Hong Kong, China). Enzyme activities of Conjugation Experiments and Plasmid AnalysisConjugation experiments were performed by the liquid mating-out assay as described (29) with streptomycin-resistant E. coli C600 as the recipient (30). Transconjugants were selected on tryptic soy agar plates supplemented by 500 µg of streptomycin and 10 µg of ceftazidime per milliliter. Plasmids from transconjugants were extracted by using a rapid alkaline lysis procedure (31). We analyzed restriction fragment length polymorphism of transferred plasmids using agarose gel electrophoresis of plasmid DNA samples treated with the restriction endonuclease EcoRI (Roche Molecular Biochemicals, Mannheim, Germany). The restricted plasmid DNA samples were then transferred to a nylon membrane (Amersham Pharmacia Biotech) and subjected to Southern hybridization. The plasmid sizes of transconjugants were estimated by adding restriction fragments. Molecular TechniquesPlasmid preparations from clinical isolates and their transconjugants
were used as templates in polymerase chain reaction (PCR) assays. Genes
related to blaTEM, blaSHV, blaCMY-1,
blacmy-2, and blaCTX-M-3 were amplified
with the oligonucleotide primers as described (23).
Primers 5'-ATAAAATTCTTGAAGACGAAA-3'and 5'-GACAGTTACCAATGCTTAATCA-3', corresponding
to nucleotides –5 to 15 and 1,074 to 1,053, respectively, of the blaTEM-1
structural gene (32), were used to amplify the entire
sequences of blaTEM-related genes. Primers AmpC-1C (5'-CTGCTGCTGACAGCCTCTTT-3')
and AmpC-1B (5'-TTTTCAAGAATGCGCCAGGC-3') (23), which
correspond to nucleotides 28–47 and 1,136–1,117, respectively, of the
blaCMY-2 structural gene (33), were
used to amplify an internal fragment of approximately 95% of blaCMY-2–related
genes. Both strands of the amplified products were sequenced on an ABI
PRISM 310 automated sequencer (Applied Biosystems, Foster City, CA). Colony
hybridization and Southern hybridization were performed as described (34,35)
with DNA probes prepared from the PCR-generated amplicons. The probes
were labeled with [ The genetic relatedness of ceftriaxone-resistant Salmonella isolates
was investigated by ribotyping by using the method described by Popovic
et al. (36). The chromosomal DNA was extracted and digested
overnight with 10 U of SphI and PstI or EcoRI (Roche
Molecular Biochemicals) (36,37). A cDNA probe was prepared
by reverse transcription of 16S plus 23S rRNA (Roche Molecular Biochemicals)
and was labeled with [ ResultsEmergence of Salmonella Isolates Producing CMY-2–Like Enzymes
Six of 384 Salmonella isolates displayed intermediate resistance
to ceftriaxone by the disk diffusion method. The isolates were recovered
from stool samples of two patients who had community-acquired enteric
infections in August and November 2000, respectively, which were identified
as S. enterica serovar Typhimurium. One isolate from each patient
(isolates ST275/00 and ST595/00) was investigated further. Both isolates
demonstrated reduced susceptibilities to ceftazidime (MIC 64 µg/mL), cefotaxime
(MIC 16 µg/mL), ceftriaxone (MIC 32 µg/mL), cefoxitin (MIC 128 µg/mL),
and amoxicillin-clavulanic acid (MIC 64 µg/mL) and were susceptible to
imipenem (MIC 0.25 µg/mL). Both isolates were susceptible to ciprofloxacin
and trimethoprim-sulfamethoxazole by the disk diffusion method. Isolate
ST275/00 was resistant to chloramphenicol, while isolate ST595/00 was
susceptible. Isoelectric focusing showed that both isolates expressed
two Prevalence of the blaCMY-2–Like Gene in E. coli and K. pneumoniae IsolatesWe found that 659 of 5,520 E. coli and 409 of 3,680 K. pneumoniae isolates showed resistance to at least one extended-spectrum cephalosporin by the disk diffusion test. These isolates were subjected to colony hybridization and PCR assays. Of these isolates, 97 E. coli isolates from 48 patients and 4 K. pneumoniae isolates from 2 patients gave a strong signal in colony hybridization with the blaCMY-2 probe and gave positive results in PCR with the primers for blaCMY-2. Sequence analysis indicated that the sequences of all amplicons were identical to the homologous region of blaCMY-2. The prevalence rates of CMY-2–like enzyme producers in E. coli increased from 0% in 1997 and 1998 to >4% in late 2000 (Figure 2). Among the patients with E. coli isolates, the incidence of patients with blaCMY-positive isolates increased from 0.0% in 1997 and 1998 to 3.6% in late 2000 (Figure 2). The sources of E. coli isolates harboring a blaCMY-2–like gene and the infections associated with these isolates are summarized in the Table. The isolates and patients are distributed according to the likely locations of infection or colonization. Of the 97 blaCMY-positive E. coli isolates, 8 isolates were likely acquired in the community by eight patients. Six of these patients had never been hospitalized, and two had been hospitalized 10 months or 2 years before isolation. K. pneumoniae isolates producing the CMY-2–like enzyme were associated with nosocomial bloodstream infections in two patients. Notably, E. coli (EC811/00) and K. pneumoniae (KP218/00) isolates were recovered from the blood sample of a single patient. Conjugation Experiments and Plasmid AnalysisOne isolate from each patient was subjected to conjugation experiments and plasmid analysis. The blaCMY-positive plasmids were successfully transferred to E. coli C600 from 2 Salmonella isolates, 40 of 48 E. coli isolates, and 2 K. pneumoniae isolates. All E. coli transconjugants and their plasmid donors showed decreased susceptibilities to ceftazidime (MIC >32 µg/mL), cefotaxime (MIC >16 µg/mL), ceftriaxone (MIC >32 µg/mL), and cefoxitin (MIC >64 µg/mL). The sizes of the transferred plasmids ranged from approximately 65 kb to >100 kb. Restricted by EcoRI, the plasmids from transconjugants of E. coli isolates showed 19 restriction patterns, designated TP1–TP19 (Figures 3A and 3C). Patterns TP17 (lane 17) and TP19 (lane 19), the most common patterns, were shown by 6 and 17 transferred plasmids, respectively. Of the 17 isolates with a TP19 plasmid, 3 were acquired from nursing homes and 5 from the community. Of the six isolates with a TP17 plasmid, two could have been acquired from the community. We considered that the remaining isolates with a TP17 or TP19 plasmid were acquired in the university hospital. Each of the remaining 17 patterns was shown by a single transferred plasmid. The TP19 pattern is the only restriction pattern displayed by transconjugants of all three studied bacterial species: Salmonella (lane 21), K. pneumoniae (lane 22), and E. coli (lane 24). Notably, K. pneumoniae isolate KP218/00 and E. coli isolate EC811/00, from the same patient, both had a TP19-type plasmid. The plasmids from transconjugants of Salmonella isolate ST275/00 (lane 20) and another K. pneumoniae isolate KP1905/00 (lane 21) showed two distinct restriction patterns. The presence of the blaCMY-2–like gene on plasmids was confirmed by Southern hybridization with the blaCMY-2 probe (Figures 3B and 3D). DiscussionEmergence of ceftriaxone-resistant salmonellae has become a great public
health concern worldwide (5-17). In Taiwan, no ceftriaxone-resistant
isolates were detected from several surveys, which included isolates collected
from 1989 to 1998 (4,20,21).
One of the surveys was conducted in National Cheng Kung University Hospital
(4), and one survey conducted in 1998 included isolates
from 22 hospitals (21). In the present study, Salmonella
isolates resistant to extended-spectrum Production of a CMY-2–like Conjugation experiments and plasmid analysis demonstrated the prevalence of conjugative resistance plasmids TP17 and TP19 among E. coli isolates. These E. coli isolates were recovered from patients hospitalized in the teaching hospital, transferred from nursing homes, or without recent hospitalization histories (Figure 3). Furthermore, the TP19 plasmid was found in a Salmonella strain and a K. pneumoniae strain, which suggests the interspecies spread of the blaCMY-2–like gene among different health-care settings and the community in Taiwan. The dissemination of the resistance determinant is probably partly because of horizontal transfer of endemic resistance plasmids. All K. pneumoniae isolates producing the CMY-2–like enzyme were acquired by patients hospitalized in the university hospital. Producers of the CMY-2–like enzyme in K. pneumoniae were not found until 2000 and, even then, remained very rare (38). Isolate KP218/00 (lane 22, Figure 3C) and E. coli isolate EC811/00 (lane 24, Figure 3C) were obtained from the same patient, and both isolates had a TP19 plasmid, suggesting interspecies spread of a resistance plasmid. Thus, the acquisition of the blaCMY-2 gene by K. pneumoniae in this hospital was likely also a recent event, which occurred after spread of the resistance determinant. Enterobacteriaceae with plasmid-encoded class C cephalosporinases are typically resistant to cephamycins, extended-spectrum cephalosporins, and monobactams (19). No standard methods exist to detect class C cephalosporinases (39). Failure to detect and report CMY-2–like enzyme producers, and a lack of infection control measures against such organisms might be partially responsible for the rapid spread of the blaCMY-2–like gene in E. coli and the increased cases of infections caused by such organisms in our hospital (Table). With the discovery of Salmonella isolates producing the CMY-2–like enzyme in Taiwan, our study suggests that the cephalosporinase could become an emerging threat, not only to hospitalized patients, but also to public health. Constant and consistent surveillance is needed to prevent its further spread.
References
|
|
||||||||||||
|
||||||||||||
![]() |
![]() |
|
![]() |
![]() |
EID Home | Top of Page | Ahead-of-Print | Past Issues | Suggested Citation | EID Search | Contact Us | Accessibility | Privacy Policy Notice | CDC Home | CDC Search | Health Topics A-Z |
![]() |
![]() |
![]() |
![]() |
This page posted February
6, 2003 |
![]() |
![]() |
![]() |
![]() |
Emerging
Infectious Diseases Journal |
![]() |
![]() |